)
Avicanna (AVCN) investor relations material
Avicanna Life Sciences Virtual Investor Forum summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Company overview and business model
Focused on evidence-based cannabinoid medicines for unmet medical needs, with four commercial divisions: medical cannabis products, a telemedicine platform, a pharmaceutical pipeline, and a raw material/API division.
Emphasizes medical and pharmaceutical applications, not recreational cannabis, targeting pain, sleep, anxiety, dermatology, oncology, and neurological disorders.
Operates MyMedi.ca, an online pharmacy/telemedicine platform providing patient support, treatment planning, and medical affairs, considered a gold standard in Canada.
Owns and supplies its own active pharmaceutical ingredients from Colombia, offering cost and quality advantages.
Commercializes products in over 20 countries, focusing on federally regulated medical and pharmaceutical markets.
Research, development, and intellectual property
Originated as a drug development company, spending initial years on R&D and clinical development, including collaborations with leading academic and clinical institutions.
Developed proprietary drug delivery technologies, such as nano-emulsion, now used in commercial products and protected by patents.
Holds several USPTO patents and a significant number of pipeline products submitted for patent approval, all developed in-house.
Clinical data and real-world evidence from platforms like MyMedi inform product development and support regulatory submissions.
Intellectual property and clinical credibility have attracted partnerships with Fortune 100 and 500 companies.
Pharmaceutical pipeline and clinical progress
Four major drug candidates in development, targeting sleep, rare skin diseases, pain management, anxiety/depression, and epilepsy.
Trunerox, the first approved pharmaceutical, launched in Colombia for Lennox-Gastaut syndrome, with plans to expand to other markets.
Phase 2 clinical trial for osteoarthritic pain underway at Toronto General Hospital/UHN, with data expected to drive further value and partnerships.
Additional topicals for rare skin diseases and inflammatory pain are in advanced development.
Plans to collaborate with larger pharmaceutical companies for late-stage clinical development and commercialization.
Next Avicanna earnings date
Next Avicanna earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)